Premier Path Wealth Partners LLC Sells 168 Shares of CME Group Inc. (NASDAQ:CME)

Premier Path Wealth Partners LLC decreased its stake in shares of CME Group Inc. (NASDAQ:CME) by 13.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,126 shares of the financial services provider’s stock after selling 168 shares during the period. Premier Path Wealth Partners LLC’s holdings in CME Group were worth $242,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Gold Investment Management Ltd. bought a new stake in CME Group in the 4th quarter valued at about $26,000. Northwest Financial Advisors acquired a new position in CME Group in the 4th quarter valued at $28,000. Harbor Investment Advisory LLC lifted its position in shares of CME Group by 966.7% during the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 145 shares during the period. BKM Wealth Management LLC acquired a new stake in shares of CME Group during the 4th quarter worth $38,000. Finally, Atticus Wealth Management LLC acquired a new position in CME Group in the third quarter valued at about $40,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of analyst reports. Barclays increased their price objective on shares of CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 25th. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday, April 25th. Rosenblatt Securities restated a “sell” rating and set a $187.00 target price (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Bank of America lifted their price target on CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Finally, JPMorgan Chase & Co. upped their price objective on CME Group from $198.00 to $206.00 and gave the stock a “neutral” rating in a research report on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and a consensus target price of $217.80.

Insider Buying and Selling at CME Group

In related news, Director Elizabeth A. Cook sold 1,000 shares of the business’s stock in a transaction on Monday, May 20th. The shares were sold at an average price of $211.52, for a total value of $211,520.00. Following the transaction, the director now owns 18,241 shares in the company, valued at $3,858,336.32. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other CME Group news, insider Hilda Harris Piell sold 7,140 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total value of $1,501,899.00. Following the transaction, the insider now directly owns 29,256 shares of the company’s stock, valued at $6,153,999.60. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Elizabeth A. Cook sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $211.52, for a total transaction of $211,520.00. Following the sale, the director now directly owns 18,241 shares of the company’s stock, valued at approximately $3,858,336.32. The disclosure for this sale can be found here. In the last 90 days, insiders sold 50,640 shares of company stock valued at $10,676,444. 0.30% of the stock is currently owned by company insiders.

CME Group Trading Up 0.5 %

Shares of CME stock traded up $1.13 during trading hours on Wednesday, hitting $211.48. 1,333,007 shares of the company’s stock traded hands, compared to its average volume of 1,763,710. The stock has a market cap of $76.15 billion, a PE ratio of 24.06, a price-to-earnings-growth ratio of 5.59 and a beta of 0.48. The stock’s 50 day simple moving average is $212.05 and its 200 day simple moving average is $211.33. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $175.73 and a 12 month high of $223.80.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.44 by $0.06. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. CME Group’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period last year, the company earned $2.42 EPS. On average, sell-side analysts anticipate that CME Group Inc. will post 9.72 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Friday, June 7th will be issued a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.18%. The ex-dividend date of this dividend is Friday, June 7th. CME Group’s payout ratio is presently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.